PWG
UTHR icon

Portside Wealth Group’s United Therapeutics UTHR Stock Holding History

Portside Wealth Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$367K Sell
678
-50
-7% -$28.2K 0.04% 360
2026
Q1 		$432K Buy
728
+25
+4% +$12.4K 0.06% 288
2025
Q4 		$343K Buy
703
+144
+26% +$67.1K 0.05% 331
2025
Q3 		$234K Buy
+559
New +$188K 0.03% 431

Other funds holding UTHR

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Portside Wealth Group's UTHR Position: Q2 2026 in Review

Portside Wealth Group reduced its United Therapeutics (UTHR) stake by 6.9% in Q2 2026, selling an estimated $28.2K and leaving 678 shares worth $367K. The position accounts for 0.04% of the portfolio, ranked #360.

Portside Wealth Group first reported a position in UTHR in Q3 2025 and has held it in 4 quarters since. The position peaked at $432K in Q1 2026. 120 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Portside Wealth Group held 678 shares of United Therapeutics worth $367K as of Q2 2026.
  • Portside Wealth Group sold 50 United Therapeutics shares in Q2 2026, an estimated $28.2K.
  • United Therapeutics made up 0.04% of Portside Wealth Group's portfolio in Q2 2026, its #360 holding.
  • Portside Wealth Group first reported a position in United Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Portside Wealth Group's United Therapeutics position peaked at $432K in Q1 2026.
  • 120 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Portside Wealth Group's 13F filing for Q2 2026, filed 14 Jul 2026.